About 40% of patients with type 2 diabetes discontinue second-line medication

Loading

By Andrew (Drew) Rhoades

Almost 40% of patients with type 2 diabetes stopped taking their second-line medication within 1 year, putting them at risk for future hospitalization related to diabetes, according to researchers.

Previous research has found alarming antidiabetic medication (ADM) usage trends because most adults with type 2 diabetes are eligible for GLP-1 receptor agonists and SGLT2 inhibitors but few use them. Read the article in Healio.

Loading

Walking faster may reduce risk for developing type 2 diabetes

Loading

By Michael Monostra

Walking at a faster speed may decrease the risk for developing type 2 diabetes, though more studies are needed to confirm the association, according to findings from a systematic review and meta-analysis.

“Currently, there is no specific instruction for gait speed in current guidelines,” Ahmad Jayedi, PhD, a research assistant at the Social Determinants of Health Research Center at Semnan University of Medical Sciences in Iran, told Healio. Read the article in Healio.

Loading

Early diagnosis, treatment intensification essential to improve diabetes outcomes

Loading

By Regina Schaffer

BOSTON — Interventions that prevent or delay the onset of type 2 diabetes are critically important, and early diagnosis and treatment intensification can improve outcomes and increase lifespan, according to a speaker.

Despite the development of several new classes of diabetes medications and devices and advances in understanding of the importance of glucose control, only about half of people with type 2 diabetes are achieving a target HbA1c of less than 7%, Juan P. Frias, MD, medical director and principal investigator at Velocity Clinical Research in Los Angeles, said during a presentation at the Cardiometabolic Health Congress. Read the complete article in Healio.

Loading

Exercise in morning or afternoon better than evening for lowering type 2 diabetes risk

Loading

By Michael Monostra

Physical activity during the morning and afternoon, but not during the evening, is associated with a lower risk for developing type 2 diabetes, according to findings published in Diabetologia.

“It is possible for the relationship between total physical activity and prospective risk for type 2 diabetes to differ by the time of day of physical activity,” Chirag J. Patel, PhD, assistant professor in the department of biomedical informatics at Harvard Medical School, told Healio. Read more in Healio.

Loading

Afternoon exercise linked to greatest HbA1c reduction in type 2 diabetes

Photo by Arek Adeoye on Unsplash
Loading

By Michael Monostra

Physical activity performed in the afternoon could yield a greater reduction in HbA1c than physical activity during other times in the day, according to an analysis of data from the Look AHEAD trial published in Diabetes Care.

“This is the first large-scale epidemiological study demonstrating that timing of unsupervised physical activity is associated with long-term improvement in blood glucose in type 2 diabetes,” Jingyi Qian, PhD, associate physiologist at Brigham and Women’s Hospital and instructor of medicine at Harvard Medical School, and Roeland J.W. Middelbeek, MD, MSc, assistant investigator and staff physician at the Joslin Diabetes Center and assistant professor of medicine at Harvard Medical School, told Healio. Read the full story in Healio.

Loading

Cognitive behavioral therapy-based intervention reduces diabetes distress for adults

Loading

By Michael Monostra
A cognitive behavioral therapy multidisciplinary intervention was associated with a reduction in HbA1c and improvements in diabetes distress for adults with type 1 and type 2 diabetes, according to study findings.

In a study published in The Science of Diabetes Self-Management and Care, researchers enrolled 29 adults with diabetes into the Diabetes Tune-Up Group, a multidisciplinary group intervention designed to deliver integrated psychoeducational, cognitive, motivational and emotional interventions in a scalable manner across six sessions. 
Read the full article in Healio.

Loading

Recent diabetes, obesity drug shortages reveal challenges for prescribers

Loading

ByErin T. Welsh, MA
ByMichael Monostra
ByJill Rollet

Recent shortages of the type 2 diabetes therapies semaglutide and tirzepatide, widely reported in the consumer press, appear to be resolving, according to manufacturers and prescribers.

Beginning in the middle of last year in the United States, but extending globally, the shortages caused numerous challenges for prescribers treating people with type 2 diabetes and with obesity. Read more in Healio.

Loading

Plant-based low-carb diet linked to lower mortality risk in type 2 diabetes

Loading

By Michael Monostra
Low-carbohydrate diets centered on macronutrients from whole grains, fruit and vegetables are associated with a lower mortality risk for people with type 2 diabetes, according to study data.

“It is well established that maintaining a higher diet quality is important for human health,” Yang Hu, ScD, research associate in the department of nutrition at the Harvard T.H. Chan School of Public Health, told Healio. Read the full story in Healio.

Loading